Bell Investment Advisors, Inc Roivant Sciences Ltd. Transaction History
Bell Investment Advisors, Inc
- $542 Million
- Q3 2024
A detailed history of Bell Investment Advisors, Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 747 shares of ROIV stock, worth $8,732. This represents 0.0% of its overall portfolio holdings.
Number of Shares
747
Previous 596
25.34%
Holding current value
$8,732
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ROIV
# of Institutions
312Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$771 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$769 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$632 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$487 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$413 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.23B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...